西替利嗪联合舒利迭治疗支气管哮喘的临床观察

摘要

Objective:To investigate the effect of cetirizine combined with seretide in the treatment of patients with bronchial asthma.Methods:100 patients with bronchial asthma were selected,they were randomly divided into the two groups on average,the control group was given antispasmodic,anti infection and symptomatic treatment,inhalation of seretide was applied at the same time,while the observation group was treated with oral administration of cetirizine on the basis of the control group,the curative effect was compared.Results:The duration of wheezing,duration of cough,shortness of breath duration,lung wheeze and moist rales duration,duration of heart rate acceleration of the observation group were significantly shorter than the control group.PEF values were significantly higher than those in the control group,there were significant differences between the two groups(P<0.05).After treatment,the total effective rate of the observation group was 100% higher than that of the control group of 80%,with significant difference(P<0.05).Conclusion:Cetirizine combined with seretide in the treatment of bronchial asthma,the clinical symptoms of patients disappear quickly,which has good curative effect.%目的：探讨西替利嗪联合舒利迭治疗支气管哮喘的治疗效果。方法：收治支气管哮喘患者100例，随机平分成两组，对照组给予解痉平喘、抗感染等对症治疗，同时雾化吸入舒利迭，观察组在对照组的基础上口服西替利嗪治疗，比较疗效。结果：观察组在喘息持续时间、咳嗽持续时间、气促持续时间、肺部有哮鸣音及湿性啰音持续时间、心率加快持续时间方面与对照组比较明显缩短，PEF 测定值明显高于对照组，两组比较，差异有统计学意义(P＜0.05)，经过治疗，观察组总有效率100.0%，高于对照组的80.0%，差异有统计学意义(P＜0.05)。结论：西替利嗪联合舒利迭治疗支气管哮喘临床症状消失快，疗效好。